GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » MARX Biotech Co Ltd (ROCO:7731) » Definitions » EV-to-EBIT

MARX Biotech Co (ROCO:7731) EV-to-EBIT : (As of Jun. 23, 2024)


View and export this data going back to 2024. Start your Free Trial

What is MARX Biotech Co EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, MARX Biotech Co's Enterprise Value is NT$4,530.8 Mil. MARX Biotech Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was NT$0.0 Mil. Therefore, MARX Biotech Co's EV-to-EBIT for today is .

The historical rank and industry rank for MARX Biotech Co's EV-to-EBIT or its related term are showing as below:

ROCO:7731' s EV-to-EBIT Range Over the Past 10 Years
Min: 0   Med: 0   Max: 1024.09
Current: 902.55

During the past 3 years, the highest EV-to-EBIT of MARX Biotech Co was 1024.09. The lowest was 0.00. And the median was 0.00.

ROCO:7731's EV-to-EBIT is ranked worse than
100% of 432 companies
in the Healthcare Providers & Services industry
Industry Median: 17.195 vs ROCO:7731: 902.55

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. MARX Biotech Co's Enterprise Value for the quarter that ended in Dec. 2023 was NT$0.0 Mil. MARX Biotech Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was NT$0.0 Mil. MARX Biotech Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was %.

MARX Biotech Co EV-to-EBIT Historical Data

The historical data trend for MARX Biotech Co's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MARX Biotech Co EV-to-EBIT Chart

MARX Biotech Co Annual Data
Trend Dec20 Dec21 Dec22
EV-to-EBIT
- - -

MARX Biotech Co Quarterly Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBIT Get a 7-Day Free Trial - - - - -

Competitive Comparison of MARX Biotech Co's EV-to-EBIT

For the Pharmaceutical Retailers subindustry, MARX Biotech Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MARX Biotech Co's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, MARX Biotech Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where MARX Biotech Co's EV-to-EBIT falls into.


MARX Biotech Co EV-to-EBIT Calculation

MARX Biotech Co's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=4530.789/0
=

MARX Biotech Co's current Enterprise Value is NT$4,530.8 Mil.
MARX Biotech Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MARX Biotech Co  (ROCO:7731) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

MARX Biotech Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=0/0
= %

MARX Biotech Co's Enterprise Value for the quarter that ended in Dec. 2023 was NT$0.0 Mil.
MARX Biotech Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MARX Biotech Co EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of MARX Biotech Co's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

MARX Biotech Co (ROCO:7731) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » MARX Biotech Co Ltd (ROCO:7731) » Definitions » EV-to-EBIT
Comparable Companies
Traded in Other Exchanges
N/A
Address
5th Floor, No. 655, Bannan Road, Zhonghe district, New Taipei, TWN
Website
https://www.marxbiotech.com
MARX Biotech Co Ltd is a retail company which has developed an O2O and OMO full-channel layout in the online Internet platform and cosmeceutical retail market, and has successfully established itself in the market and Build trust and operational growth on the channel side. It has has established more than three thousand large and small cosmeceutical pharmacies in Taiwan, including: Dashu Pharmacy, Dingding Pharmacy, Cosmed, Watsons, Spring Pharmacy, New Gaoqiao Pharmacy, Anlier Pharmacies, etc.

MARX Biotech Co (ROCO:7731) Headlines

No Headlines